Status:
UNKNOWN
Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
Lead Sponsor:
Herlev Hospital
Conditions:
Breast Neoplasms
Mastectomy
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Background Seroma formation is a common problem after mastectomy. The incidence various between 30% to 92%. It is often an ongoing problem after removal of the suction drain, and repeated skin punctur...
Detailed Description
Background Seroma formation is a common problem after mastectomy. The incidence various between 30% to 92%. It is often an ongoing problem after removal of the suction drain, and repeated skin punctur...
Eligibility Criteria
Inclusion
- Women with primary breast cancer, planned for a mastectomy with and axillary dissection.
- Age over 18 years
- signed informed consent.
Exclusion
- Men
- Treatment with glucocorticoids within the last month before surgery, including inhalation products
- Pregnant.
- Not able to speak danish
- Severe heart disease
- Treatment with carbamazepine, phenytoin, phenobarbital, rifampicin, salicylates and ciclosporin
- Uræmia
- Diabetes
- Other medical conditions, evaluated by the investigator, that make tke patient unfit for participation
- previous psychosis
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00307606
Start Date
December 1 2005
End Date
December 1 2007
Last Update
September 6 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev Hospital, breast surgery
Herlev, Copenhagen, Denmark, 2730